2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... exacerbations Drug Class ... Dosing: 250 mcg tablet ... it eosinophils are ... won’t have any clinical
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
ASA class If ... event, follow ACC algorithm ... Change in clinical ... ACEi/ARBs - Hold ... Determine if any labs are